All News

Dead Words Eulogy Cover Image

Dead Words Eulogy

d Jack Cush, MD

The trouble with rheumatology may be the words we live by. Welcome to the eulogy for rheumatology 'dead words'. We're here today to celebrate the loss of rheumatology past. These are dead words in rheumatology, words fortified unfortunately by history and habit. The lexicon of rheumatology is unique, it's challenging and it's mostly incomprehensible to those who don't know...but those are the cornerstones of the greatest of medical subspecialties. 

Read Article
antibody (Keep)

Anti-Drug Antibodies and Biologic Drug Responses

d Jack Cush, MD

A prospective cohort study suggests the presence of antidrug antibodies may be associated with bDMARDs nonresponse in rheumatoid arthritis (RA). Should we be monitoring ADAbs (especially in nonresponders)?

Read Article
heart,CV,MI.cardia,

Prevalence of Cardiovascular Disease in Rheumatoid Arthritis

d Jack Cush, MD

A prospective study of the BioSTAR registry estimates the prevalence of cardiovascular disease in rheumatoid arthritis (RA) to be 4.6%.

Read Article
coronavirus,COVID,MISC,mask

Best Treatments for COVID-Related MIS-C

d Jack Cush, MD

The RECOVERY trial focused on pediatric MIS-C patients treated with immunomodulators and anti-cytokine therapy demonstrated the benefits of first-line therapy with intravenous methylprednisolone or second-line tocilizumab in children refractory to initial treatment.

Read Article
We are so excited for #RNL2024 tomorrow! Will you be attending? It's not too late to join virtually. We hope you can make it! https://t.co/Zkev3KMI3K https://t.co/E5LzuPuHFy

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2024 Preview! Our Spondyloarthitis Spectrum pod features Drs. Eric Ruderman, Lihi Eder and Lianne Gensler. There's still time to register: https://t.co/Qc7rdBfDV0 https://t.co/2tYfxkQfdO

Links:

Dr. John Cush RheumNow ( View Tweet)
#RNL2024 Speaker Preview! Be sure to check out our Vasculitis Mavens this weekend! Drs. Catherine Sims, Anisha Dua, and Philip Seo will be leading exciting talks. https://t.co/inDKp0JsFu https://t.co/L32LqWrvUM

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinics - Sponsored By https://t.co/4UQlqwujiR Check out our recent QD clinics in one spot! https://t.co/WcPt6bzEXM https://t.co/EIWuKq4CjN

Links:

Dr. John Cush RheumNow ( View Tweet)
Best Treatments for COVID-Related MIS-C https://t.co/6Ntdug1eam https://t.co/x6de0DQTZ9

Links:

Dr. John Cush RheumNow ( View Tweet)
Norweigian nationwide study shows males with inflamm Jt. Dz (IJD) have more children and are less likely to be childless compared with matched controls. Males w/ IJD may be reassured that no impairment of fertility is expected https://t.co/PPv8vnkd0m https://t.co/ZepV4ZEfVn

Links:

Dr. John Cush RheumNow ( View Tweet)
16% of patients with nr-axSpA progressed to r-axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti-inflammatory drugs were predictors of radiographic progression https://t.co/eargDLHUZ2 https://t.co/xG52uMmYK8

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of 235 newly Dx #RA patients (157 females) found that 11 pts (5%) had carpal tunnel syndrom (CTS) at the time of initial RA diagnosis. Such pts were more likey to be older, female, CCP negative and have a longer Sx duration. https://t.co/0CfF0lKBgk https://t.co/tx9CvQ4TWX

Links:

Dr. John Cush RheumNow ( View Tweet)
No evidence of harm starting urate lowering Tx (ULT) during #gout attack. Metanalysis 6 RCTs (445 pts) w/ gout attacks given ULT vs PBO or delayed ULT. No differences in pain, time to resolve gout flare or risk of recurrent gout flare in 30d (RR 1.06) https://t.co/xUX2U6MmGP https://t.co/2bV0g2FOSK

Links:

Dr. John Cush RheumNow ( View Tweet)
Meta-analysis of 35 RCTs (>20K pts) with inflammatory skin disorders shows that w/ short-term (<5 mos) use JAK inhibitors do not significantly increase risk of all-cause mortality (OR, 0.83; 0.44-1.57), MACE, or VTE (OR, 0.52; 0.26-1.04). https://t.co/zBlcZ02QqQ https://t.co/cXjswVS9lF

Links:

Dr. John Cush RheumNow ( View Tweet)
Microbiome study of 16 SLE pts (44 fecal samples) shows that blooms of Ruminococcus gnavus pathobiont was assoc w/ lupus flares and may be the drivers of clinical of relapsing lupus disease https://t.co/OXA4L6kG4p https://t.co/zXX7ZfWik1

Links:

Dr. John Cush RheumNow ( View Tweet)
2019 NHIS chronic pain study shows signif disparity in nonpharmacologic & integrative medicine (IHM) use by populations. More IHM with city living, higher income & education, widespread pains. Less IHM w/ elderly, males, Blacks, opioid use, depression https://t.co/uoOyQBXTmy https://t.co/yTTVc5zljG

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us this weekend! More than 25 sessions on topics ranging from spondyloarthritis, PsA, vasculitis and lupus to JAK inhibitors, RA, artificial intelligence and myositis. CME and MOC offered. Learn more about our program and registration options today! https://t.co/6uWDDIUnvA https://t.co/aWk4IKZYC4

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Applauds Prior Authorization Rule The ACR applauds the CMS for finalizing its Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations rule recently. https://t.co/ZVPl2bUT3g https://t.co/ynynH0A8XN

Links:

Dr. John Cush RheumNow ( View Tweet)
Severe Hypocalcemia Risk w/Denosumab and CKD Patients On 1/19 the FDA issued a Drug Safety Communication about the risk of severe hypocalcemia in CKD patients taking denosumab for osteoporosis. https://t.co/VPpIZBZQkm https://t.co/yxFYn1ob5A

Links:

Dr. John Cush RheumNow ( View Tweet)
What do you know about monogenic and polygenic autoinflammatory diseases? Join Drs Liebowitz and Mehta as they review the challenges of these conditions. https://t.co/z0mTZEwFkP https://t.co/LAxl2eFZKR

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×